Sun Pharmaceutical Industries, Inc.: OSHA inspections and violations
Cranbury, New Jersey · Pharmaceutical Preparation Manufacturing · NAICS 325412
1inspections
2citation items
$9,620current penalties
Mar 8, 2016last inspection
OSHA inspectors have visited Sun Pharmaceutical Industries, Inc. in New Jersey one time.
It opened on Mar 8, 2016 after a complaint, in Cranbury.
In all, OSHA issued 2 citation items: 2 serious.
The proposed penalties came to $16,034; today they stand at $9,620, 40% less.
Among manufacturing employers, the typical cited inspection since 2015 ends with a $4,500 penalty. Sun Pharmaceutical Industries, Inc. averages $9,620 across 1 cited inspection.
Sun Pharmaceutical Industries, Inc. also files yearly injury logs with OSHA, summarized below.
Citation items per year, by inspection date.
New Jersey · latest 90 days of OSHA records
276employers cited
Get notified the morning OSHA posts each new citation in New Jersey: the employer, the site address, the rules broken and the penalty.
Checking a subcontractor, a client or your own company? Watch Sun Pharmaceutical Industries, Inc. and get notified the morning OSHA posts a new citation for it.
From the Form 300A summaries employers file with OSHA each year. Rate = recordable cases per 100 full-time workers.
In 2018, the Cranbury site logged 1 recordable injury or illness among about 325 workers: 0.3 per 100 full-time workers, against a median of 1.1 for its industry.
Site and year
Workers
Cases
Days-away cases
Rate
Industry median
Cranbury 1
Cranbury · 2018
325
1
0
0.3
1.1
Included with any plan: 2 more yearly logs from these sites, back to 2016, with each site's average rate over its latest three years. Already a subscriber? Sign in.
Alert subscribers get notified of each newly cited employer in New Jersey the morning it is posted. See the alert plans.
Source: U.S. Department of Labor, OSHA enforcement data. A citation is OSHA's allegation; employers can contest it, and the status column shows where each item stands. Something wrong on this page? Tell us.